APC and neoplasm: CRCs also harbor a high incidence of other mutations that often arise as a secondary event after Wnt/β-catenin dysregulation (multistep somatic evolution model) such as in KRAS, BRAF, TP53, P13K and/or SMAD4 that cooperate with APC loss to further drive tumor progression [1].